Daewoong Co.,Ltd. ("DWC") - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-01-29
9:24 pm
Purchase
2026-01-2113DAEON Biopharma, Inc.
AEON
Daewoong Co.,Ltd. ("DWC")12,009,737
49.990%
11,918,380increase
(+13045.94%)
Filing
History
2026-01-29
9:03 pm
Sale
2025-03-2413DAEON Biopharma, Inc.
AEON
Daewoong Co.,Ltd. ("DWC")91,357
0.900%
-6,486,247decrease
(-98.61%)
Filing
History
2023-07-28
07:55 am
Purchase
2023-07-2813DAEON Biopharma, Inc.
AEON
Daewoong Co.,Ltd. ("DWC")91,356
23.980%
91,356increase
(New Position)
Filing
History